Combining Flt3-L and poly-I:C treatment induces expansion and activation of CD103+ cDC1 from DC progenitors within the tumor and enhances the efficacy of checkpoint therapy blockade in experimental models of melanoma [41] and glioblastoma [163]. This evidence concerns the gene ITGAE and melanoma.